|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-000
|
|
IUPAC
|
|
methyl 5-methyl-2-{5-methyl-4-[3-(trifluoromethyl)phenoxymethyl]-1,2-oxazole-3-amido}thiophene-3-carboxylate
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-001
|
|
IUPAC
|
|
{[5-bromo-2-(2-methylpropoxy)phenyl]methyl}(tert-butyl)amine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-002
|
|
IUPAC
|
|
methyl 4-(2-chloro-4-hydroxy-3-iodo-5-methoxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-003
|
|
IUPAC
|
|
N-cyclopentyl-3-(4-methoxyphenyl)-4,5-dihydro-1,2-oxazole-5-carboxamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-004
|
|
IUPAC
|
|
N-[(5-bromo-2-propoxyphenyl)methyl]cyclohexanamine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-005
|
|
IUPAC
|
|
ethyl 2-(N-cyclopropylacetamido)-4-methyl-1,3-thiazole-5-carboxylate
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-006
|
|
IUPAC
|
|
7-(1,3-dimethyl-1H-pyrazol-4-yl)-5-methyl-2-(methylsulfanyl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-007
|
|
IUPAC
|
|
3-(4-fluorophenyl)-5-[(4-methylpiperidin-1-yl)carbonyl]-4,5-dihydro-1,2-oxazole
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-008
|
|
IUPAC
|
|
(NE)-3-(butylsulfanyl)-5-(difluoromethyl)-N-[(4-methylphenyl)methylidene]-4H-1,2,4-triazol-4-amine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-009
|
|
IUPAC
|
|
9-(1-ethyl-1H-pyrazol-5-yl)-4H,5H,6H,7H,8H,9H-[1,2,4]triazolo[3,2-b]quinazolin-8-one
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-010
|
|
IUPAC
|
|
7-(4-chlorophenyl)-5-methyl-N-(1,3-thiazol-2-yl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-011
|
|
IUPAC
|
|
6-(2-methylbutan-2-yl)-3-thia-1,12-diazapentacyclo[11.7.0.0^{2,10}.0^{4,9}.0^{14,19}]icosa-2(10),4(9),12,14,16,18-hexaen-11-one
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-012
|
|
IUPAC
|
|
{[3-chloro-5-ethoxy-4-(prop-2-en-1-yloxy)phenyl]methyl}(propan-2-yl)amine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-013
|
|
IUPAC
|
|
2-{4-[(butylamino)methyl]-2-ethoxyphenoxy}-N-(2-methylphenyl)acetamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-014
|
|
IUPAC
|
|
methyl 4-(2-chloro-5-ethoxy-4-methoxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-015
|
|
IUPAC
|
|
5-methyl-4-[3-(trifluoromethyl)phenoxymethyl]-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-3-carboxamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-016
|
|
IUPAC
|
|
4-[3-cyclopropyl-1-phenyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-1-methyl-1H-pyrazole
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-017
|
|
IUPAC
|
|
11,13-dimethyl-4-[2-(4-nitro-1H-pyrazol-1-yl)ethyl]-16-thia-3,5,6,8,14-pentaazatetracyclo[7.7.0.0^{2,6}.0^{10,15}]hexadeca-1(9),2,4,7,10,12,14-heptaene
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-018
|
|
IUPAC
|
|
4-[(3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)methyl]-11,13-dimethyl-16-thia-3,5,6,8,14-pentaazatetracyclo[7.7.0.0^{2,6}.0^{10,15}]hexadeca-1(9),2,4,7,10,12,14-heptaene
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-019
|
|
IUPAC
|
|
6-[(5-chlorothiophen-2-yl)carbonyl]-7-(4-ethoxyphenyl)-5-(trifluoromethyl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-020
|
|
IUPAC
|
|
N-(1-ethyl-1H-pyrazol-4-yl)-5-methyl-4-[3-(trifluoromethyl)phenoxymethyl]-1,2-oxazole-3-carboxamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-021
|
|
IUPAC
|
|
2-[(6-ethoxy-1,3-benzothiazol-2-yl)sulfanyl]-1-{3-[(4-methylphenyl)carbonyl]imidazolidin-1-yl}ethan-1-one
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-022
|
|
IUPAC
|
|
(NE)-3-(methylsulfanyl)-N-{[5-(2,3,4,5,6-pentachlorophenoxymethyl)furan-2-yl]methylidene}-4H-1,2,4-triazol-4-amine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-023
|
|
IUPAC
|
|
(4E)-13-(1,3-dimethyl-1H-pyrazol-5-yl)-9-phenyl-4-(phenylmethylidene)-2-oxa-12,14,15,17-tetraazatetracyclo[8.7.0.0^{3,8}.0^{11,15}]heptadeca-1(10),3(8),11,13,16-pentaene
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-024
|
|
IUPAC
|
|
2-amino-4-[4-(benzyloxy)-3-methoxyphenyl]-6-methyl-3,4,5,6,7,8-hexahydronaphthalene-1,3,3-tricarbonitrile
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-025
|
|
IUPAC
|
|
4-(4-bromo-1,3-dimethyl-1H-pyrazol-5-yl)-11,13-dimethyl-16-thia-3,5,6,8,14-pentaazatetracyclo[7.7.0.0^{2,6}.0^{10,15}]hexadeca-1(9),2,4,7,10,12,14-heptaene
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-026
|
|
IUPAC
|
|
N-{[2-chloro-5-ethoxy-4-(prop-2-en-1-yloxy)phenyl]methyl}-2-methylcyclohexan-1-amine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-027
|
|
IUPAC
|
|
2-[4-(2,2-dicyanoeth-1-en-1-yl)-2-methoxyphenoxy]-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)acetamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-028
|
|
IUPAC
|
|
{[2-(4-bromophenoxymethyl)phenyl]methyl}(propan-2-yl)amine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-029
|
|
IUPAC
|
|
2-{4-[(cyclohexylamino)methyl]-2-iodo-6-methoxyphenoxy}acetamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-030
|
|
IUPAC
|
|
5-methyl-N-[2-(1H-pyrazol-1-yl)ethyl]-4-[3-(trifluoromethyl)phenoxymethyl]-1,2-oxazole-3-carboxamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-031
|
|
IUPAC
|
|
(4E)-13-(1-ethyl-1H-pyrazol-4-yl)-9-phenyl-4-(phenylmethylidene)-2-oxa-12,14,15,17-tetraazatetracyclo[8.7.0.0^{3,8}.0^{11,15}]heptadeca-1(10),3(8),11,13,16-pentaene
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-032
|
|
IUPAC
|
|
7-(1,5-dimethyl-1H-pyrazol-4-yl)-N-(2-methoxyphenyl)-5-methyl-2-(methylsulfanyl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-033
|
|
IUPAC
|
|
N-benzyl-2-(2-iodo-6-methoxy-4-{[(2-phenylethyl)amino]methyl}phenoxy)acetamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-034
|
|
IUPAC
|
|
7-(1-ethyl-1H-pyrazol-3-yl)-5-methyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-035
|
|
IUPAC
|
|
2-{2-methoxy-4-[(methylamino)methyl]phenoxy}-N-phenylacetamide
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-036
|
|
IUPAC
|
|
N-[(3-chloro-5-methoxy-4-propoxyphenyl)methyl]cyclohexanamine
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-037
|
|
IUPAC
|
|
methyl 7-(furan-3-yl)-5-methyl-2-(methylsulfanyl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-038
|
|
IUPAC
|
|
4-{6-[(furan-2-yl)carbonyl]-5-(trifluoromethyl)-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}-1,3-dimethyl-1H-pyrazole
|
|
|
|
|
|
|
|
|
Compound Number
|
|
MolPort-002-767-039
|
|
IUPAC
|
|
1-ethyl-4-[(E)-[(2-methylphenyl)methylidene]amino]-1H-pyrazole-5-carboxamide
|
|
|
|